Literature DB >> 16326106

Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3-carboxylates.

Chunshen Zhao1, Yanfang Zhao, Huifang Chai, Ping Gong.   

Abstract

A series of ethyl 5-hydroxy-1H-indole-3-carboxylates 6A-10T were synthesized and evaluated for their anti-hepatitis B virus (HBV) activities in 2.2.15 cells. The IC50 and selective index of inhibition on replication of HBV DNA of compounds 10(L) (1.52 microg/ml, 9.38) and 10(P) (2.00 microg/ml, 8.85) were higher than those of the other evaluated compounds including lamivudine (7.02). Compounds 7E and 10J exhibited significant anti-HBV activities, and the IC50 values on replication of HBV DNA of these compounds were 24.90 and 15.41 microg/ml, respectively, which were far more potent than the positive control lamivudine 228.00 microg/ml.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326106     DOI: 10.1016/j.bmc.2005.11.033

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

Review 1.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

2.  Identification of novel 5-hydroxy-1H-indole-3-carboxylates with anti-HBV activities based on 3D QSAR studies.

Authors:  Hui-Fang Chai; Xin-Xia Liang; Lin Li; Chun-Shen Zhao; Ping Gong; Zhong-Jie Liang; Wei-Liang Zhu; Hua-Liang Jiang; Cheng Luo
Journal:  J Mol Model       Date:  2010-10-30       Impact factor: 1.810

3.  The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses.

Authors:  Eve-Isabelle Pécheur; Viktoriya Borisevich; Peter Halfmann; John D Morrey; Donald F Smee; Mark Prichard; Chad E Mire; Yoshihiro Kawaoka; Thomas W Geisbert; Stephen J Polyak
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

Review 4.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

Review 5.  Metal-Promoted Heterocyclization: A Heterosynthetic Approach to Face a Pandemic Crisis.

Authors:  Federico Vittorio Rossi; Dario Gentili; Enrico Marcantoni
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

Review 6.  Discovery and development of anti-HBV agents and their resistance.

Authors:  Kyun-Hwan Kim; Nam Doo Kim; Baik-Lin Seong
Journal:  Molecules       Date:  2010-08-27       Impact factor: 4.411

7.  Synthesis and antifungal activity of novel sulfone derivatives containing 1,3,4-oxadiazole moieties.

Authors:  Weiming Xu; Jiang He; Ming He; Feifei Han; Xuehai Chen; Zhaoxi Pan; Jian Wang; Maoguo Tong
Journal:  Molecules       Date:  2011-11-01       Impact factor: 4.411

Review 8.  New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection.

Authors:  Bauso Luana Vittoria; Chiara Imbesi; Gasparo Irene; Gabriella Calì; Alessandra Bitto
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-25

9.  The Antiviral Drug Arbidol Inhibits Zika Virus.

Authors:  Susan L Fink; Lucia Vojtech; Jessica Wagoner; Natalie S J Slivinski; Konner J Jackson; Ruofan Wang; Sudip Khadka; Priya Luthra; Christopher F Basler; Stephen J Polyak
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

10.  Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers.

Authors:  Ming-Yan Liu; Shuang Wang; Wei-Fan Yao; Hui-zhe Wu; Sheng-Nan Meng; Min-Jie Wei
Journal:  Clin Ther       Date:  2009-04       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.